HK1020728A1 - Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid - Google Patents

Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid

Info

Publication number
HK1020728A1
HK1020728A1 HK99105756A HK99105756A HK1020728A1 HK 1020728 A1 HK1020728 A1 HK 1020728A1 HK 99105756 A HK99105756 A HK 99105756A HK 99105756 A HK99105756 A HK 99105756A HK 1020728 A1 HK1020728 A1 HK 1020728A1
Authority
HK
Hong Kong
Prior art keywords
improved process
synthesis
pct
dihydroxybutyric acid
protected esters
Prior art date
Application number
HK99105756A
Other languages
English (en)
Inventor
Thomas Elliott Jacks
Donald Eugene Butler
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of HK1020728A1 publication Critical patent/HK1020728A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/03Preparation of carboxylic acid esters by reacting an ester group with a hydroxy group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/30Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D317/34Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrane Compounds (AREA)
HK99105756A 1996-07-29 1999-12-09 Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid HK1020728A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2236996P 1996-07-29 1996-07-29
PCT/US1997/011654 WO1998004543A1 (en) 1996-07-29 1997-07-01 Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid

Publications (1)

Publication Number Publication Date
HK1020728A1 true HK1020728A1 (en) 2000-05-19

Family

ID=21809241

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99105756A HK1020728A1 (en) 1996-07-29 1999-12-09 Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid

Country Status (18)

Country Link
US (1) US5998633A (hu)
EP (1) EP0915866B1 (hu)
JP (1) JP2000515882A (hu)
KR (1) KR100447370B1 (hu)
CN (1) CN1093126C (hu)
AT (1) ATE215078T1 (hu)
AU (1) AU3515497A (hu)
CO (1) CO4950542A1 (hu)
DE (1) DE69711391T2 (hu)
DK (1) DK0915866T3 (hu)
ES (1) ES2176756T3 (hu)
HK (1) HK1020728A1 (hu)
HU (1) HU226465B1 (hu)
IL (1) IL127058A (hu)
PT (1) PT915866E (hu)
TR (1) TR199900191T2 (hu)
WO (1) WO1998004543A1 (hu)
ZA (1) ZA976705B (hu)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998633A (en) * 1996-07-29 1999-12-07 Warner-Lambert Company Process for the synthesis of protected esters of (S)-3,4-dihydroxybutyric acid
KR100332703B1 (ko) * 1998-07-24 2002-08-27 삼성정밀화학 주식회사 광학활성을갖는(s)-3,4-에폭시부티르산염의제조방법
ES2183586T3 (es) 1998-07-24 2003-03-16 Samsung Fine Chemicals Co Ltd Procedimiento continuo para la preparacion de (s) -3- hidroxi- gamma- butirolactona opticamente pura.
US6713290B2 (en) 1998-07-24 2004-03-30 Samsung Fine Chemicals Co., Ltd. Process for preparing optically pure (S)-3-hydroxy-γ-butyrolactone
US6235930B1 (en) * 1999-03-31 2001-05-22 Board Of Trustees Operating Michigan State University Process for the preparation of 3,4-dihydroxybutanoic acid and derivatives thereof from substituted pentose sugars
HU227840B1 (en) * 1999-05-06 2012-05-02 Egis Gyogyszergyar Nyilvanosan M Kod Ruszvunytarsasag Intermediates of atorvastatin synthesis and process for producing them
EP1584616A1 (en) 1999-12-17 2005-10-12 Pfizer Science and Technology Ireland Limited Industrial process for the production of crystalline atorvastatin trihydrate hemi calcium salt
ES2258030T3 (es) * 1999-12-17 2006-08-16 Pfizer Science And Technology Ireland Limited Procedimiento para producir atorvastatina calcio cristalina.
JP4598917B2 (ja) * 2000-04-28 2010-12-15 ダイセル化学工業株式会社 ラクトンの製造方法
KR100645665B1 (ko) 2000-07-27 2006-11-13 에스케이 주식회사 (s)-베타-하이드록시-감마-부티로락톤의 연속 제조방법
US6476235B2 (en) * 2001-01-09 2002-11-05 Warner-Lambert Company Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide
EP1728785A1 (en) 2001-01-09 2006-12-06 Warner-Lambert Company LLC 7-[(2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-heptanoic acid ester 3,5-dioxo-acetal
WO2002057229A1 (en) * 2001-01-19 2002-07-25 Biocon India Limited FORM V CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-ß,$G(D)-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1- HEPTANOIC ACID HEMI CALCIUM SALT. (ATORVASTATIN)
CN1524073A (zh) 2001-06-29 2004-08-25 ����-�����ع�˾ ′R-(R*,R*)-2-(4-氟苯基)-β,δ-二羟基-5-(1-甲基乙基)-3-苯基-4-(苯基氨基)羰基-1H-吡咯-1-庚酸钙盐(2∶1)(阿托伐他汀)
EP1406860A1 (en) * 2001-07-06 2004-04-14 Teva Pharmaceutical Industries Limited Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives
KR100598079B1 (ko) * 2002-02-25 2006-07-07 바이오콘 리미티드 신규의 보로네이트 에스테르
GB0211716D0 (en) 2002-05-22 2002-07-03 Phoenix Chemicals Ltd Process
PL375415A1 (en) 2002-08-06 2005-11-28 Warner-Lambert Company Llc Process for preparing 5-(4-fluorophenyl)-1-[2-((2r,4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)ethyl]-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
WO2004026223A2 (en) * 2002-09-18 2004-04-01 Sk Corporation CONTINUOUS PROCESS FOR THE PRODUCTION OF OPTICALLY PURE (S)-β HYDROXY-Ϝ-BUTYROLACTONE
EP1625223A4 (en) * 2002-09-20 2009-11-11 Verenium Corp CHEMOENZYMATIC PROCEDURES FOR SYNTHESIS OF STATINES AND STATIN INTERCONNECTIONS
US6713639B1 (en) 2002-10-28 2004-03-30 Council Of Scientific And Industrial Research Process for preparing enantiomerically pure (S)-3-hydroxy-gamma-butyrolactone
CN1774421A (zh) * 2003-04-14 2006-05-17 沃尼尔·朗伯有限责任公司 制备5-(4-氟苯基)-1-[2-((2r,4r)-4-羟基-6-氧代-四氢-吡喃-2-基)乙基]-2-异丙基-4-苯基-1h-吡咯-3-羧酸苯基酰胺的方法
WO2004094343A1 (en) * 2003-04-22 2004-11-04 Biocon Limited NOVEL PROCESS FOR STEREOSELECTIVE REDUCTION OF ß-KETOESTERS
US7790197B2 (en) * 2003-06-09 2010-09-07 Warner-Lambert Company Llc Pharmaceutical compositions of atorvastatin
US20040253305A1 (en) * 2003-06-12 2004-12-16 Luner Paul E. Pharmaceutical compositions of atorvastatin
US7655692B2 (en) * 2003-06-12 2010-02-02 Pfizer Inc. Process for forming amorphous atorvastatin
US20050271717A1 (en) 2003-06-12 2005-12-08 Alfred Berchielli Pharmaceutical compositions of atorvastatin
CN1852894A (zh) * 2003-09-17 2006-10-25 沃尼尔·朗伯有限责任公司 [R-(R*, R*)]-2-(4-氟苯基) -β,δ-二羟基-5-(1-甲基乙基) -3-苯基-4-[(苯基氨基)羰基] -1 H-吡咯-1-庚酸的结晶形式
WO2005068642A2 (en) 2003-10-01 2005-07-28 Board Of Trustees Operating Michigan State University Bacterial synthesis of 1,2,4-butanetriol enantiomers
BRPI0509923A (pt) * 2004-04-16 2007-09-18 Pfizer Prod Inc processo para formação de cálcio de atorvastatina amorfa
CA2564030C (en) 2004-05-05 2010-06-08 Pfizer Products Inc. Salt forms of [r-(r*, r*)]-2-(4-fluorophenyl)-.beta., .delta.-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid
JP2008506764A (ja) 2004-07-20 2008-03-06 ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー [R−(R*,R*)]−2−(4−フルオロフェニル)−β、δ−ジヒドロキシ−5−(1−メチルエチル)−3−フェニル−4−[(フェニルアミノ)カルボニル]−1H−ピロール−1−ヘプタン酸カルシウム塩(2:1)の新規形態
EP1807055A1 (en) 2004-10-28 2007-07-18 Warner-Lambert Company LLC Process for forming amorphous atorvastatin
CA2589537A1 (en) * 2004-12-02 2006-06-08 Stephen Craig Dyar Pharmaceutical compositions of amorphous atorvastatin and process for preparing same
WO2006129649A1 (ja) * 2005-05-31 2006-12-07 Kowa Co., Ltd. 光学活性ppar活性化化合物及びその製造中間体の製造法
CA2547216A1 (en) 2005-09-21 2007-03-21 Renuka D. Reddy Process for annealing amorphous atorvastatin
DE602006014193D1 (de) 2005-11-21 2010-06-17 Warner Lambert Co Neue formen von är-(r*,r*)ü-2-(4-fluorphenyl)-b,d-dihydroxy-5-(1-methylethyl)-3-phenyl-4-ä(phenylamino)carbonylü-1h-pyrrol-1-heptansäure-magnesium
US20110165641A1 (en) * 2006-03-31 2011-07-07 The Board Of Trustees Of Michigan State University Synthesis of 1,2,4-Butanetriol Enantiomers from Carbohydrates
US20110076730A1 (en) * 2006-07-19 2011-03-31 Board Of Trustees Of Michigan State University Microbial synthesis of d-1,2,4-butanetriol
KR100850558B1 (ko) 2008-01-02 2008-08-06 조동옥 아토르바스타틴의 효율적인 제조방법
JP2009256316A (ja) 2008-03-28 2009-11-05 Daicel Chem Ind Ltd β−ヒドロキシ−γ−ブチロラクトンの製造方法
CN101337906B (zh) * 2008-08-15 2012-06-27 河南豫辰精细化工有限公司 一种4-甲基-3-氧代-n-苯基戊酰胺的制备方法
EP2373609B1 (en) 2008-12-19 2013-10-16 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
EP2327682A1 (en) 2009-10-29 2011-06-01 KRKA, D.D., Novo Mesto Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates
US20140335179A1 (en) 2011-07-01 2014-11-13 Dsm Sinochem Pharmaceuticals Netherlands B.V. Micronized crystals of atorvastatin hemicalcium
CN106397241A (zh) * 2016-08-23 2017-02-15 杨锋 一种4‑甲基‑3‑氧代‑n‑苯基戊酰胺的绿色环保后处理方法
CN106588689A (zh) * 2016-12-15 2017-04-26 河南豫辰药业股份有限公司 一种从结晶母液废液中回收阿托伐他汀中间体m4的方法
CN112939901B (zh) * 2021-02-09 2023-05-09 中国科学院福建物质结构研究所 一种α-羟基-γ-丁内酯的制备方法
CN114195670B (zh) * 2021-12-31 2024-03-15 河南豫辰药业股份有限公司 一种阿托伐他汀母核m4的精制方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2710688B2 (ja) * 1990-10-09 1998-02-10 鐘淵化学工業株式会社 4―ブロモ―3―ヒドロキシ酪酸エステル誘導体の製造法
CA2049536C (en) * 1991-05-13 1999-07-06 Rawle I. Hollingsworth Process for the preparation of 3,4-dihydroxybutanoic acid and salts thereof
JP3351563B2 (ja) * 1992-12-03 2002-11-25 鐘淵化学工業株式会社 3−ヒドロキシ酪酸誘導体の製造法
US5998633A (en) * 1996-07-29 1999-12-07 Warner-Lambert Company Process for the synthesis of protected esters of (S)-3,4-dihydroxybutyric acid

Also Published As

Publication number Publication date
DE69711391T2 (de) 2002-11-07
EP0915866A1 (en) 1999-05-19
WO1998004543A1 (en) 1998-02-05
TR199900191T2 (xx) 1999-04-21
PT915866E (pt) 2002-07-31
ATE215078T1 (de) 2002-04-15
ES2176756T3 (es) 2002-12-01
US5998633A (en) 1999-12-07
ZA976705B (en) 1998-02-10
IL127058A0 (en) 1999-09-22
CN1093126C (zh) 2002-10-23
EP0915866B1 (en) 2002-03-27
JP2000515882A (ja) 2000-11-28
AU3515497A (en) 1998-02-20
DK0915866T3 (da) 2002-06-10
HU226465B1 (en) 2008-12-29
CN1223647A (zh) 1999-07-21
HUP9904348A3 (en) 2004-03-01
KR100447370B1 (ko) 2004-09-08
HUP9904348A2 (hu) 2000-04-28
KR20000029648A (ko) 2000-05-25
CO4950542A1 (es) 2000-09-01
DE69711391D1 (de) 2002-05-02
IL127058A (en) 2001-07-24

Similar Documents

Publication Publication Date Title
IL127058A0 (en) Improved process for the synthesis of protected esters of (s)-3,4-dihydroxybutyric acid
DE69831868D1 (en) Antithrombosemittel
BG106340A (en) Substituted oxoazaheterocyclyl compounds
MY121760A (en) Benzothiazin and benzoxazin derivatives;their preparation and uses
YU47600A (sh) SUPSTITUISANI OKSOAZAHETEROCIKLIL INHIBITORI FAKTORA Xa
IL133623A0 (en) Antithrombotic agents
HK1019878A1 (en) Total synthesis of antitumor acylfulvenes.
UA41291C2 (uk) ФТОРОВАНІ ПОХІДНІ 17<font face="Symbol">b</font>-ЗАМІЩЕНОГО-4-AЗA-5<font face="Symbol">a-</font>АНДРОСТАН-3-ОНУ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЇХ ОСНОВІ
MY116862A (en) New processes for preparing pesticidal intermediates
MY103214A (en) Antihypercholesterolemic tetrazole compounds
IL136100A0 (en) Biphenylamidine derivatives, prodrugs thereof and pharmaceutical compositions containing the same
AP1519A (en) Process for the preparation of thiazolidinedione derivatives.
UA66866C2 (uk) Синтез морфолінових похідних
HUP0004413A2 (hu) 2-Aril-3-aroil-benzo[b]tiofének alkalmazása ösztrogén elvonási szindróma kezelésére alkalmas gyógyszerkészítmények előállítására
SI1102765T1 (en) PROCESS FOR THE SYNTHESIS OF (1$i(H))-BENZO C)QUINOLIZIN-3-ONES DERIVATIVES
AU3285000A (en) 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
ES8608499A1 (es) Procedimiento de preparar derivados iminotiazolidinicos
PL343546A1 (en) Processes for preparing intermediates
AU2971997A (en) Intermediates for oligonucleotide synthesis
UA42798C2 (uk) Аналоги 15-дезоксиспергуаліну, спосіб їх одержання, проміжні сполуки, фармацевтична композиція на основі аналогів 15-дезоксипергуаліну
YU71400A (sh) Poboljšani postupak za pripremanje farmaceutski dragocenih derivata norbenzomorfana
ES8604210A1 (es) Procedimiento para preparar 2- (fenetil) -5- (3,4-metilen- dioxi)-x-hidroxibencil) -pirrolidina
MX9801926A (es) Procedimiento para la preparacion de derivados de arilalquinil-n-hidroxiurea que tienen actividad inhibidora de lipoxigenasa.
MX9605794A (es) Intermediario para preparar un compuesto farmaceuticamente activo.
TW254937B (en) Benzocycloheptene derivative and process for preparation thereof

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090701